Statements (95)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:acquisition |
gptkb:Warner-Lambert
gptkb:Hospira gptkb:Array_Bio_Pharma Wyeth |
| gptkbp:ceo |
gptkb:Albert_Bourla
2019-present |
| gptkbp:clinical_trial |
gptkb:diabetes
gptkb:vaccine oncology rare diseases hematology neuroscience vaccines dermatology cardiovascular diseases biologics infectious diseases immunology pain management vaccine development women's health respiratory diseases ophthalmology transplantation urology gastroenterology men's health |
| gptkbp:collaboration |
gptkb:GSK
|
| gptkbp:conducts_research_on |
gptkb:Mikael_Dolsten
|
| gptkbp:covid-19_impact |
vaccine development
|
| gptkbp:employees |
approximately 78,500 (2020)
|
| gptkbp:founded |
1849
|
| gptkbp:founder |
gptkb:Charles_Pfizer_Jr.
|
| gptkbp:global_presence |
over 125 countries
|
| gptkbp:headquarters |
gptkb:New_York_City
gptkb:Manhattan,_New_York |
| https://www.w3.org/2000/01/rdf-schema#label |
Pfizer Inc.
|
| gptkbp:industry |
gptkb:pharmaceuticals
Pharmaceuticals |
| gptkbp:invention |
numerous pharmaceutical patents
|
| gptkbp:is_vulnerable_to |
gptkb:BNT162b2
gptkb:Comirnaty |
| gptkbp:market_cap |
$220 billion (2021)
|
| gptkbp:partnership |
gptkb:Moderna
gptkb:Bio_NTech |
| gptkbp:philanthropy |
gptkb:Pfizer_Foundation
Disaster relief efforts Community health programs Global health initiatives Access to medicines |
| gptkbp:products |
Antibiotics
Vaccines medications vaccines Oncology drugs |
| gptkbp:related_products |
gptkb:Zoloft
gptkb:Comirnaty gptkb:Lipitor Viagra Prevnar |
| gptkbp:research_and_development |
gptkb:Cardiovascular_diseases
gptkb:Oncology Gene therapy Immunology Neurology Vaccines Biopharmaceuticals Rare diseases Inflammatory diseases $8.6 billion (2020) |
| gptkbp:revenue |
41.9 billion USD (2020)
$41.9 billion (2020) |
| gptkbp:stock_exchange |
gptkb:NYSE
|
| gptkbp:stock_symbol |
PFE
|
| gptkbp:subsidiaries |
Wyeth
|
| gptkbp:subsidiary |
Wyeth
|
| gptkbp:sustainability |
Diversity and inclusion initiatives
Environmental responsibility Health and safety standards Ethical business practices Water conservation efforts Sustainable sourcing Innovation in healthcare Carbon footprint reduction Waste reduction initiatives Employee training and development Employee engagement programs Community investment Transparency in reporting Supply chain responsibility |
| gptkbp:sustainability_initiatives |
environmental responsibility
|
| gptkbp:website |
www.pfizer.com
|
| gptkbp:bfsParent |
gptkb:Bill_Gates
|
| gptkbp:bfsLayer |
3
|